Published in Curr Genomics on March 01, 2008
Toll-like receptors and human disease: lessons from single nucleotide polymorphisms. Curr Genomics (2012) 0.92
Genetic regulation of expression of leukotriene A4 hydrolase. ERJ Open Res (2016) 0.75
Vascular Genetic Variants and Ischemic Stroke Susceptibility in Albanians from the Republic of Macedonia. Open Access Maced J Med Sci (2016) 0.75
A second generation human haplotype map of over 3.1 million SNPs. Nature (2007) 85.39
Atherosclerosis--an inflammatory disease. N Engl J Med (1999) 59.28
The structure of haplotype blocks in the human genome. Science (2002) 50.88
Inflammation in atherosclerosis. Nature (2002) 28.92
PANTHER: a library of protein families and subfamilies indexed by function. Genome Res (2003) 21.64
High-resolution haplotype structure in the human genome. Nat Genet (2001) 20.51
Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell (1997) 15.96
Blocks of limited haplotype diversity revealed by high-resolution scanning of human chromosome 21. Science (2001) 15.54
Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science (1988) 13.54
The human LDL receptor: a cysteine-rich protein with multiple Alu sequences in its mRNA. Cell (1984) 12.54
Low LDL cholesterol in individuals of African descent resulting from frequent nonsense mutations in PCSK9. Nat Genet (2005) 12.12
Mutations in PCSK9 cause autosomal dominant hypercholesterolemia. Nat Genet (2003) 11.67
Population stratification and spurious allelic association. Lancet (2003) 10.53
Role of transforming growth factor beta in human disease. N Engl J Med (2000) 10.17
Evidence for a gene influencing blood pressure on chromosome 17. Genome scan linkage results for longitudinal blood pressure phenotypes in subjects from the framingham heart study. Hypertension (2000) 8.84
TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat Genet (2000) 8.79
A family of human receptors structurally related to Drosophila Toll. Proc Natl Acad Sci U S A (1998) 8.40
Genetic susceptibility to death from coronary heart disease in a study of twins. N Engl J Med (1994) 7.47
Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency. Nat Genet (1999) 7.30
Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1. Nat Genet (1999) 7.04
A first-generation linkage disequilibrium map of human chromosome 22. Nature (2002) 7.03
The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease. Nat Genet (1999) 6.92
Accumulation of dietary cholesterol in sitosterolemia caused by mutations in adjacent ABC transporters. Science (2000) 6.73
Human genes involved in cholesterol metabolism: chromosomal mapping of the loci for the low density lipoprotein receptor and 3-hydroxy-3-methylglutaryl-coenzyme A reductase with cDNA probes. Proc Natl Acad Sci U S A (1985) 5.33
The gene encoding 5-lipoxygenase activating protein confers risk of myocardial infarction and stroke. Nat Genet (2004) 5.31
Recognition of pathogen-associated molecular patterns by TLR family. Immunol Lett (2003) 5.27
CD36 is a sensor of diacylglycerides. Nature (2005) 5.20
Chromosome-wide distribution of haplotype blocks and the role of recombination hot spots. Nat Genet (2003) 5.03
Applications for protein sequence-function evolution data: mRNA/protein expression analysis and coding SNP scoring tools. Nucleic Acids Res (2006) 5.02
Molecular genetics of the LDL receptor gene in familial hypercholesterolemia. Hum Mutat (1992) 4.48
A variant of the gene encoding leukotriene A4 hydrolase confers ethnicity-specific risk of myocardial infarction. Nat Genet (2005) 4.45
Autosomal recessive hypercholesterolemia caused by mutations in a putative LDL receptor adaptor protein. Science (2001) 4.32
Scavenger receptors class A-I/II and CD36 are the principal receptors responsible for the uptake of modified low density lipoprotein leading to lipid loading in macrophages. J Biol Chem (2002) 4.17
Human Toll-like receptor 4 recognizes host-specific LPS modifications. Nat Immunol (2002) 3.56
What makes a good genetic association study? Lancet (2005) 3.46
A genomewide linkage study of 1,933 families affected by premature coronary artery disease: The British Heart Foundation (BHF) Family Heart Study. Am J Hum Genet (2005) 3.20
A comprehensive linkage analysis for myocardial infarction and its related risk factors. Nat Genet (2002) 3.19
Toll-like receptors: key mediators of microbe detection. Curr Opin Immunol (2002) 3.16
Toll-like receptor-4 is expressed by macrophages in murine and human lipid-rich atherosclerotic plaques and upregulated by oxidized LDL. Circulation (2001) 3.15
Disruption of Abcg5 and Abcg8 in mice reveals their crucial role in biliary cholesterol secretion. Proc Natl Acad Sci U S A (2002) 3.09
Genetic control of the circulating concentration of transforming growth factor type beta1. Hum Mol Genet (1999) 3.08
Inhibition of transforming growth factor-beta signaling accelerates atherosclerosis and induces an unstable plaque phenotype in mice. Circ Res (2001) 3.07
Coding single-nucleotide polymorphisms associated with complex vs. Mendelian disease: evolutionary evidence for differences in molecular effects. Proc Natl Acad Sci U S A (2004) 3.03
Heterogeneity of apolipoprotein B: isolation of a new species from human chylomicrons. Proc Natl Acad Sci U S A (1980) 2.88
Identification of a gene, ABCG5, important in the regulation of dietary cholesterol absorption. Nat Genet (2001) 2.84
The Tangier disease gene product ABC1 controls the cellular apolipoprotein-mediated lipid removal pathway. J Clin Invest (1999) 2.77
Germline mutations and sequence variants of the macrophage scavenger receptor 1 gene are associated with prostate cancer risk. Nat Genet (2002) 2.76
The LDL-receptor-related protein, LRP, is an apolipoprotein E-binding protein. Nature (1989) 2.75
Beta-sitosterolemia and xanthomatosis. A newly described lipid storage disease in two sisters. J Clin Invest (1974) 2.73
Abnormal lipoprotein receptor-binding activity of the human E apoprotein due to cysteine-arginine interchange at a single site. J Biol Chem (1982) 2.71
Association between a specific apolipoprotein B mutation and familial defective apolipoprotein B-100. Proc Natl Acad Sci U S A (1989) 2.68
Toll-like receptors and innate immunity. J Mol Med (Berl) (2006) 2.65
Human apolipoprotein E. The complete amino acid sequence. J Biol Chem (1982) 2.64
Human very low density lipoprotein apolipoprotein E isoprotein polymorphism is explained by genetic variation and posttranslational modification. Biochemistry (1981) 2.61
The class B scavenger receptors SR-BI and CD36 are receptors for anionic phospholipids. J Biol Chem (1995) 2.58
Sequence diversity and large-scale typing of SNPs in the human apolipoprotein E gene. Genome Res (2000) 2.53
A mutation in PCSK9 causing autosomal-dominant hypercholesterolemia in a Utah pedigree. Hum Genet (2004) 2.53
Haplotypes and SNPs in 13 lipid-relevant genes explain most of the genetic variance in high-density lipoprotein and low-density lipoprotein cholesterol. Hum Mol Genet (2004) 2.45
Inflammatory response after open heart surgery: release of heat-shock protein 70 and signaling through toll-like receptor-4. Circulation (2002) 2.44
Stimulation of endothelial cell migration by vascular permeability factor/vascular endothelial growth factor through cooperative mechanisms involving the alphavbeta3 integrin, osteopontin, and thrombin. Am J Pathol (1996) 2.42
The serum concentration of active transforming growth factor-beta is severely depressed in advanced atherosclerosis. Nat Med (1995) 2.42
Heritability of death from coronary heart disease: a 36-year follow-up of 20 966 Swedish twins. J Intern Med (2002) 2.42
Recent progress in understanding apolipoprotein B. Circulation (1990) 2.38
Premature myocardial infarction novel susceptibility locus on chromosome 1P34-36 identified by genomewide linkage analysis. Am J Hum Genet (2004) 2.36
Osteopontin: a versatile regulator of inflammation and biomineralization. Matrix Biol (2000) 2.24
Osteoprotegerin reverses osteoporosis by inhibiting endosteal osteoclasts and prevents vascular calcification by blocking a process resembling osteoclastogenesis. J Exp Med (2000) 2.20
Combinatorial pattern recognition receptor signaling alters the balance of life and death in macrophages. Proc Natl Acad Sci U S A (2006) 2.19
A genome-wide scan for coronary heart disease suggests in Indo-Mauritians a susceptibility locus on chromosome 16p13 and replicates linkage with the metabolic syndrome on 3q27. Hum Mol Genet (2001) 2.17
Nucleotide sequence and structure of the human apolipoprotein E gene. Proc Natl Acad Sci U S A (1985) 2.16
Matrix metalloproteinases in lung: multiple, multifarious, and multifaceted. Physiol Rev (2007) 2.14
Mutations in the PCSK9 gene in Norwegian subjects with autosomal dominant hypercholesterolemia. Clin Genet (2004) 2.00
Regulation of bile acid synthesis: pathways, nuclear receptors, and mechanisms. J Hepatol (2004) 1.98
Genetics of the apolipoprotein E system in man. Am J Hum Genet (1980) 1.94
Evidence for a gene influencing the TG/HDL-C ratio on chromosome 7q32.3-qter: a genome-wide scan in the Framingham study. Hum Mol Genet (2000) 1.94
Two loci on chromosomes 2 and X for premature coronary heart disease identified in early- and late-settlement populations of Finland. Am J Hum Genet (2000) 1.93
Familial defective apolipoprotein B-100: low density lipoproteins with abnormal receptor binding. Proc Natl Acad Sci U S A (1987) 1.93
Role of heparan sulfate proteoglycans in the binding and uptake of apolipoprotein E-enriched remnant lipoproteins by cultured cells. J Biol Chem (1993) 1.92
Familial defective apolipoprotein B-100: a mutation of apolipoprotein B that causes hypercholesterolemia. J Lipid Res (1990) 1.90
Human macrophage scavenger receptors: primary structure, expression, and localization in atherosclerotic lesions. Proc Natl Acad Sci U S A (1990) 1.87
Activation of transforming growth factor-beta is inhibited in transgenic apolipoprotein(a) mice. Nature (1994) 1.87
Assignment of the human gene for the low density lipoprotein receptor to chromosome 19: synteny of a receptor, a ligand, and a genetic disease. Proc Natl Acad Sci U S A (1984) 1.86
Biochemistry and cell biology of mammalian scavenger receptors. Atherosclerosis (2005) 1.85
A three codon insertion/deletion polymorphism in the signal peptide region of the human apolipoprotein B (APOB) gene directly typed by the polymerase chain reaction. Nucleic Acids Res (1989) 1.77
Genome-wide linkage analysis of the acute coronary syndrome suggests a locus on chromosome 2. Arterioscler Thromb Vasc Biol (2002) 1.76
Novel polymorphisms in promoter region of atp binding cassette transporter gene and plasma lipids, severity, progression, and regression of coronary atherosclerosis and response to therapy. Circ Res (2001) 1.74
Osteopontin promotes vascular cell adhesion and spreading and is chemotactic for smooth muscle cells in vitro. Circ Res (1994) 1.73
Inflammation in atherosclerosis and implications for therapy. Circulation (2004) 1.71
Common genetic variation in ABCA1 is associated with altered lipoprotein levels and a modified risk for coronary artery disease. Circulation (2001) 1.71
A genomewide scan for early-onset coronary artery disease in 438 families: the GENECARD Study. Am J Hum Genet (2004) 1.71
Autosomal recessive hypercholesterolaemia in Sardinia, Italy, and mutations in ARH: a clinical and molecular genetic analysis. Lancet (2002) 1.69
A genome-wide scan of serum lipid levels in the Old Order Amish. Atherosclerosis (2004) 1.69
A genome-wide linkage scan for dietary energy and nutrient intakes: the Health, Risk Factors, Exercise Training, and Genetics (HERITAGE) Family Study. Am J Clin Nutr (2004) 1.68
Allelic polymorphisms in the transcriptional regulatory region of apolipoprotein E gene. FEBS Lett (1998) 1.64
Cloning of two novel ABC transporters mapping on human chromosome 9. Genomics (1994) 1.63
Increased matrix metalloproteinase-9 activity in unstable carotid plaques. A potential role in acute plaque disruption. Stroke (2000) 1.59
HDL apolipoproteins and ABCA1: partners in the removal of excess cellular cholesterol. Arterioscler Thromb Vasc Biol (2003) 1.57
Toll-like receptor 4 gene polymorphisms and myocardial infarction: no association in a Caucasian population. Eur Heart J (2006) 1.56
Mapping a gene involved in regulating dietary cholesterol absorption. The sitosterolemia locus is found at chromosome 2p21. J Clin Invest (1998) 1.55
Association of hypo-responsive toll-like receptor 4 variants with risk of myocardial infarction. Eur Heart J (2004) 1.54
Retracted Effect of ramipril on walking times and quality of life among patients with peripheral artery disease and intermittent claudication: a randomized controlled trial. JAMA (2013) 4.88
In older men an optimal plasma testosterone is associated with reduced all-cause mortality and higher dihydrotestosterone with reduced ischemic heart disease mortality, while estradiol levels do not predict mortality. J Clin Endocrinol Metab (2013) 3.11
Reduced expansion rate of abdominal aortic aneurysms in patients with diabetes may be related to aberrant monocyte-matrix interactions. Eur Heart J (2008) 2.21
Common variants at 6p21.1 are associated with large artery atherosclerotic stroke. Nat Genet (2012) 1.81
Association of statin prescription with small abdominal aortic aneurysm progression. Am Heart J (2010) 1.67
150 minutes of vigorous physical activity per week predicts survival and successful ageing: a population-based 11-year longitudinal study of 12 201 older Australian men. Br J Sports Med (2013) 1.67
Abdominal aortic aneurysm is associated with a variant in low-density lipoprotein receptor-related protein 1. Am J Hum Genet (2011) 1.60
Osteoprotegerin, vascular calcification and atherosclerosis. Atherosclerosis (2008) 1.51
Lower plasma testosterone or dihydrotestosterone, but not estradiol, is associated with symptoms of intermittent claudication in older men. Clin Endocrinol (Oxf) (2013) 1.45
Serum carboxymethyllysine concentrations are reduced in diabetic men with abdominal aortic aneurysms: Health In Men Study. J Vasc Surg (2009) 1.41
Barriers to screening and diagnosis of peripheral artery disease by general practitioners. Vasc Med (2013) 1.41
Osteoprotegerin and osteopontin are expressed at high concentrations within symptomatic carotid atherosclerosis. Stroke (2004) 1.34
Engineering of the rose flavonoid biosynthetic pathway successfully generated blue-hued flowers accumulating delphinidin. Plant Cell Physiol (2007) 1.29
Whole genome expression analysis within the angiotensin II-apolipoprotein E deficient mouse model of abdominal aortic aneurysm. BMC Genomics (2009) 1.22
Pioglitazone-induced reductions in atherosclerosis occur via smooth muscle cell-specific interaction with PPAR{gamma}. Circ Res (2010) 1.22
Angiotensin II type 1 receptor 1166C polymorphism is associated with abdominal aortic aneurysm in three independent cohorts. Arterioscler Thromb Vasc Biol (2008) 1.21
Quantification of abdominal aortic calcification on CT. Arterioscler Thromb Vasc Biol (2006) 1.19
Assessment of a serum assay for quantification of abdominal aortic calcification. Arterioscler Thromb Vasc Biol (2006) 1.14
A sequence variant associated with sortilin-1 (SORT1) on 1p13.3 is independently associated with abdominal aortic aneurysm. Hum Mol Genet (2013) 1.10
Animal models of abdominal aortic aneurysm and their role in furthering management of human disease. Cardiovasc Pathol (2010) 1.09
Control of salt and volume retention cannot be ruled out as a mechanism underlying the blood pressure-lowering effect of renal denervation. Hypertens Res (2013) 1.09
Sequence variant on 9p21 is associated with the presence of abdominal aortic aneurysm disease but does not have an impact on aneurysmal expansion. Eur J Hum Genet (2008) 1.09
Regarding "a meta-analysis of clinical studies of statins for prevention of abdominal aortic aneurysm expansion". J Vasc Surg (2011) 1.07
Atherosclerosis and abdominal aortic aneurysm: cause, response, or common risk factors? Arterioscler Thromb Vasc Biol (2010) 1.06
Association of osteoprotegerin with human abdominal aortic aneurysm progression. Circulation (2005) 1.06
Cognitive dysfunction in mice deficient for TNF- and its receptors. Am J Med Genet B Neuropsychiatr Genet (2008) 1.05
Diagnosis and monitoring of abdominal aortic aneurysm: current status and future prospects. Curr Probl Cardiol (2010) 1.03
Relationship between temporal-spatial gait parameters, gait kinematics, walking performance, exercise capacity, and physical activity level in peripheral arterial disease. J Vasc Surg (2007) 1.02
Biomechanical characteristics of peripheral diabetic neuropathy: A systematic review and meta-analysis of findings from the gait cycle, muscle activity and dynamic barefoot plantar pressure. Clin Biomech (Bristol, Avon) (2013) 1.01
Association between IL-8 cytokine and cognitive performance in an elderly general population--the MEMO-Study. Neurobiol Aging (2007) 1.01
A systematic review of studies examining inflammation associated cytokines in human abdominal aortic aneurysm samples. Dis Markers (2009) 1.01
A variant in LDLR is associated with abdominal aortic aneurysm. Circ Cardiovasc Genet (2013) 1.00
Osteoprotegerin upregulates endothelial cell adhesion molecule response to tumor necrosis factor-alpha associated with induction of angiopoietin-2. Cardiovasc Res (2007) 1.00
Matrix biology of abdominal aortic aneurysms in diabetes: mechanisms underlying the negative association. Connect Tissue Res (2007) 0.97
Regulation of peroxisome proliferator-activated receptor-γ by angiotensin II via transforming growth factor-β1-activated p38 mitogen-activated protein kinase in aortic smooth muscle cells. Arterioscler Thromb Vasc Biol (2011) 0.96
Matricellular protein CCN3 mitigates abdominal aortic aneurysm. J Clin Invest (2016) 0.96
Genetic and epigenetic mechanisms and their possible role in abdominal aortic aneurysm. Atherosclerosis (2010) 0.96
Interaction between angiotensin II, osteoprotegerin, and peroxisome proliferator-activated receptor-gamma in abdominal aortic aneurysm. J Vasc Res (2008) 0.96
Downregulation of transforming growth factor, beta receptor 2 and Notch signaling pathway in human abdominal aortic aneurysm. Atherosclerosis (2012) 0.95
Meta-analysis of the association between single nucleotide polymorphisms in TGF-β receptor genes and abdominal aortic aneurysm. Atherosclerosis (2011) 0.95
Effects of a long-term exercise program on lower limb mobility, physiological responses, walking performance, and physical activity levels in patients with peripheral arterial disease. J Vasc Surg (2008) 0.94
Impaired acetylcholine-induced endothelium-dependent aortic relaxation by caveolin-1 in angiotensin II-infused apolipoprotein-E (ApoE-/-) knockout mice. PLoS One (2013) 0.92
Higher free thyroxine levels are associated with all-cause mortality in euthyroid older men: the Health In Men Study. Eur J Endocrinol (2013) 0.92
The association of genetic variants of matrix metalloproteinases with abdominal aortic aneurysm: a systematic review and meta-analysis. Heart (2013) 0.91
The potential role of homocysteine mediated DNA methylation and associated epigenetic changes in abdominal aortic aneurysm formation. Atherosclerosis (2013) 0.91
Are myocardial infarction--associated single-nucleotide polymorphisms associated with ischemic stroke? Stroke (2012) 0.91
Association of an allele on chromosome 9 and abdominal aortic aneurysm. Atherosclerosis (2010) 0.91
The calcium chloride-induced rodent model of abdominal aortic aneurysm. Atherosclerosis (2012) 0.91
Fenofibrate increases high-density lipoprotein and sphingosine 1 phosphate concentrations limiting abdominal aortic aneurysm progression in a mouse model. Am J Pathol (2012) 0.90
microRNA profiling in patients with abdominal aortic aneurysms: the significance of miR-155. Clin Sci (Lond) (2014) 0.89
The intermittent claudication questionnaire: a patient-assessed condition-specific health outcome measure. J Vasc Surg (2002) 0.89
The role of thrombospondin-1 in cardiovascular health and pathology. Int J Cardiol (2013) 0.88
Osteocalcin positive mononuclear cells are associated with the severity of aortic calcification. Atherosclerosis (2009) 0.88
Outcome of endovascular treatment of acute type B aortic dissection. Ann Thorac Surg (2008) 0.88
Assessment of the association between genetic polymorphisms in transforming growth factor beta, and its binding protein (LTBP), and the presence, and expansion, of Abdominal Aortic Aneurysm. Atherosclerosis (2009) 0.88
Association of PPARgamma allelic variation, osteoprotegerin and abdominal aortic aneurysm. Clin Endocrinol (Oxf) (2009) 0.87
Role of homocysteine in aortic calcification and osteogenic cell differentiation. Atherosclerosis (2008) 0.87
Intralimb coordination variability in peripheral arterial disease. Clin Biomech (Bristol, Avon) (2007) 0.87
Angiopoietins, abdominal aortic aneurysm and atherosclerosis. Atherosclerosis (2010) 0.87
Plasma total homocysteine is associated with abdominal aortic aneurysm and aortic diameter in older men. J Vasc Surg (2013) 0.86
Relevance of urocortins to cardiovascular disease. J Mol Cell Cardiol (2011) 0.86
Meta-analysis of the association between transforming growth factor-beta polymorphisms and complications of coronary heart disease. PLoS One (2012) 0.85
Alcohol consumption and cognitive impairment in older men: a mendelian randomization study. Neurology (2014) 0.85
Increased plasma levels of NGAL, a marker of neutrophil activation, in patients with abdominal aortic aneurysm. Atherosclerosis (2011) 0.85
Transforming growth factor-β and abdominal aortic aneurysms. Cardiovasc Pathol (2012) 0.85
Osteoprotegerin is associated with aneurysm diameter and proteolysis in abdominal aortic aneurysm disease. Arterioscler Thromb Vasc Biol (2012) 0.85
Associations of total testosterone, sex hormone-binding globulin, calculated free testosterone, and luteinizing hormone with prevalence of abdominal aortic aneurysm in older men. J Clin Endocrinol Metab (2010) 0.85
The association of obesity with cardiovascular events in patients with peripheral artery disease. Atherosclerosis (2013) 0.85
Neuronal nitric oxide synthase and sympathetic nerve activity in neurovascular and metabolic systems. Curr Neurovasc Res (2013) 0.84
The association between the gene encoding 5-lipoxygenase activating protein and abdominal aortic aneurysms. Atherosclerosis (2011) 0.84
Association of single nucleotide polymorphisms in the gene encoding platelet endothelial cell adhesion molecule-1 with the risk of myocardial infarction: a systematic review and meta-analysis. Thromb Res (2013) 0.83
Meta-analysis of whole-genome linkage scans for intracranial aneurysm. Neurosci Lett (2007) 0.83
A meta-analysis of the outcome of endovascular and noninvasive therapies in the treatment of intermittent claudication. J Vasc Surg (2011) 0.83
Retracted Potential vascular mechanisms of ramipril induced increases in walking ability in patients with intermittent claudication. Circ Res (2014) 0.83
Reference intervals for bone turnover markers and their association with incident hip fractures in older men: the Health in Men study. J Clin Endocrinol Metab (2015) 0.82
Folic acid, vitamin B12, MTHFR genotypes, and plasma homocysteine. Clin Chem (2006) 0.82
Everolimus limits aortic aneurysm in the apolipoprotein E-deficient mouse by downregulating C-C chemokine receptor 2 positive monocytes. Arterioscler Thromb Vasc Biol (2013) 0.82
Thrombus volume is associated with cardiovascular events and aneurysm growth in patients who have abdominal aortic aneurysms. J Vasc Surg (2011) 0.82
Comparison of the serum lipidome in patients with abdominal aortic aneurysm and peripheral artery disease. Circ Cardiovasc Genet (2014) 0.82
Serum osteoprotegerin as a biomarker for vascular disease. Am J Cardiol (2007) 0.82
Proteomic analysis of intra-arterial thrombus secretions reveals a negative association of clusterin and thrombospondin-1 with abdominal aortic aneurysm. Atherosclerosis (2011) 0.82
Lower limb movement variability in patients with peripheral arterial disease. Clin Biomech (Bristol, Avon) (2008) 0.81
Targeting chemokines in aortic aneurysm: could this be key to a novel therapy for a common problem? Arterioscler Thromb Vasc Biol (2013) 0.81
Proteomic and genomic analyses suggest the association of apolipoprotein C1 with abdominal aortic aneurysm. Proteomics Clin Appl (2014) 0.81
Circulating concentrations of stem-cell-mobilizing cytokines are associated with levels of osteoprogenitor cells and aortic calcification severity. Circ J (2011) 0.81
The association of obesity with abdominal aortic aneurysm presence and growth. Atherosclerosis (2012) 0.81
Aliskiren limits abdominal aortic aneurysm, ventricular hypertrophy and atherosclerosis in an apolipoprotein-E-deficient mouse model. Clin Sci (Lond) (2014) 0.80
Effects of a 6-month exercise program pilot study on walking economy, peak physiological characteristics, and walking performance in patients with peripheral arterial disease. Vasc Health Risk Manag (2012) 0.80
Comparison of volume and diameter measurement in assessing small abdominal aortic aneurysm expansion examined using computed tomographic angiography. Eur J Radiol (2010) 0.80
A risk table to assist health practitioners assess and prevent the onset of depression in later life. Prev Med (2013) 0.80
Relation of infra-renal abdominal aortic calcific deposits and cardiovascular events in patients with peripheral artery disease. Am J Cardiol (2010) 0.79
Therapeutic effects of renal denervation on renal failure. Curr Neurovasc Res (2013) 0.79
Intensive versus conventional glycaemic control for treating diabetic foot ulcers. Cochrane Database Syst Rev (2016) 0.79
Osteo-progenitors in vascular calcification: a circulating cell theory. J Atheroscler Thromb (2011) 0.79
Is there a new target in the renin-angiotensin system for aortic aneurysm therapy? Arterioscler Thromb Vasc Biol (2013) 0.79
A meta-analysis of randomised controlled trials assessing drug-eluting stents and vascular brachytherapy in the treatment of coronary artery in-stent restenosis. Int J Cardiol (2007) 0.79
Urocortin 2 is associated with abdominal aortic aneurysm and mediates anti-proliferative effects on vascular smooth muscle cells via corticotrophin releasing factor receptor 2. Clin Sci (Lond) (2014) 0.79
Influence of peripheral arterial disease and supervised walking on heart rate variability. J Vasc Surg (2011) 0.78